Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 516.96%90.13M | 95.27%224.39M | 112.40%82.79M | -0.77%26.68M | 44.71%114.92M | 38.98M | 83.07%26.89M | 91.50%34.44M | 35.67%14.61M | 9.07%79.41M |
| Cost of revenue | 446.12%74.4M | 79.09%178.64M | 54.94%55.69M | 3.91%23.3M | 36.96%99.75M | 35.94M | 65.02%22.42M | 62.33%27.77M | 33.79%13.62M | 16.50%72.83M |
| Gross profit | 1,495.64%15.73M | 201.66%45.75M | 792.69%27.1M | -24.24%3.39M | 130.62%15.17M | 3.04M | 305.44%4.47M | 659.91%6.67M | 68.26%986K | -36.07%6.58M |
| Operating expense | 206.65%1.94M | 130.09%1.75M | 181.43%7.07M | -14.98%999K | -252.39%-5.83M | -8.68M | 53.19%1.18M | 46.63%1.04M | 51.56%632K | 260.16%3.83M |
| Selling and administrative expenses | ---- | --7.16M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -1.80%4.22M |
| -Selling and marketing expense | ---- | --2.48M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 9.25%1.14M |
| -General and administrative expense | ---- | --4.68M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -5.36%3.07M |
| Other operating expenses | 146.35%2.03M | 171.20%11.1M | 1,158.52%12.93M | -11.91%1.04M | 100,787.57%4.09M | --1.03M | 37.59%1.18M | 36.03%1.08M | -17.47%822K | --4.06K |
| Total other operating income | -54.21%87K | 66.27%16.5M | -39.70%5.86M | --36K | 2,422.88%9.92M | --9.71M | ---- | -59.49%32K | -67.18%190K | -94.11%393.32K |
| Operating profit | 3,796.89%13.8M | 109.53%43.99M | 70.95%20.03M | -27.54%2.39M | 663.59%21M | 11.72M | 881.25%3.3M | 3,290.36%5.63M | 109.47%354K | -78.31%2.75M |
| Net non-operating interest income (expenses) | -1,305.33%-1.05M | -812.94%-9.38M | -1,423.72%-7.13M | -20.11%-448K | 74.11%-1.03M | -468K | -1,392.00%-373K | -288.14%-111K | -22.95%-75K | -3,764.68%-3.97M |
| Non-operating interest income | 98.95%189K | 61.09%770K | 16.26%143K | 23.14%149K | 202.53%478K | --123K | 764.29%121K | 120.63%139K | 150.00%95K | --158K |
| Non-operating interest expense | 631.18%1.24M | 522.98%9.38M | 1,130.80%7.27M | 20.85%597K | -62.06%1.51M | --591K | 1,166.67%494K | 6,150.00%250K | 71.72%170K | 3,764.68%3.97M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 189.24K | 112.00%153.98K | ||||||||
| Less:Write off | ---- | ---189.24K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -112.00%-153.98K |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 4,466.67%12.74M | 74.30%34.81M | 14.68%12.9M | -33.62%1.94M | 1,978.93%19.97M | 11.25M | 840.19%2.92M | 2,352.00%5.52M | 158.33%279K | -109.41%-1.06M |
| Income tax | 2,524.82%3.6M | 213.98%10.35M | 364.56%6.54M | 59.95%651K | 233.82%3.3M | 1.41M | 307.00%407K | 3,638.89%1.35M | 137K | -21.35%987.96K |
| Net income | 6,340.14%9.15M | 46.67%24.45M | -35.38%6.36M | -48.75%1.29M | 912.95%16.67M | 9.84M | 1,092.89%2.52M | 2,106.88%4.17M | 31.48%142K | -120.44%-2.05M |
| Net income continuous operations | 6,340.14%9.15M | 46.67%24.45M | -35.38%6.36M | -48.75%1.29M | 912.95%16.67M | --9.84M | 1,092.89%2.52M | 2,106.88%4.17M | 31.48%142K | -120.44%-2.05M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to the company | 6,340.14%9.15M | 46.67%24.45M | -35.38%6.36M | -48.75%1.29M | 912.95%16.67M | 9.84M | 1,092.89%2.52M | 2,106.88%4.17M | 31.48%142K | -120.44%-2.05M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 6,340.14%9.15M | 46.67%24.45M | -35.38%6.36M | -48.75%1.29M | 912.95%16.67M | 9.84M | 1,092.89%2.52M | 2,106.88%4.17M | 31.48%142K | -120.44%-2.05M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 5,925.00%0.0241 | 46.70%0.0644 | -35.14%0.0168 | -48.48%0.0034 | 912.96%0.0439 | 0.0259 | 1,000.00%0.0066 | 2,100.00%0.011 | 33.33%0.0004 | -120.38%-0.0054 |
| Diluted earnings per share | 5,925.00%0.0241 | 46.70%0.0644 | -35.14%0.0168 | -48.48%0.0034 | 912.96%0.0439 | 0.0259 | 1,000.00%0.0066 | 2,100.00%0.011 | 33.33%0.0004 | -120.38%-0.0054 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.